These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31059702)

  • 1. Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: A 36-month follow-up cohort study.
    Wang H; Li N; Shao X; Li J; Guo L; Yu X; Sun Y; Hao J; Niu H; Xiang J; Li X; Han X
    Clin Chim Acta; 2019 Aug; 495():338-344. PubMed ID: 31059702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure.
    Ye J; Wang Z; Ye D; Wang Y; Wang M; Ji Q; Huang Y; Liu L; Shi Y; Shi L; Zeng T; Xu Y; Liu J; Jiang H; Lin Y; Wan J
    Mediators Inflamm; 2019; 2019():1575410. PubMed ID: 30728748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Corin as a Predictor of Cardiovascular Events in Patients With Chronic Heart Failure.
    Zhou X; Chen JC; Liu Y; Yang H; Du K; Kong Y; Xu XH
    JACC Heart Fail; 2016 Aug; 4(8):664-9. PubMed ID: 27179834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    O'Donoghue M; Chen A; Baggish AL; Anwaruddin S; Krauser DG; Tung R; Januzzi JL
    J Card Fail; 2005 Jun; 11(5 Suppl):S9-14. PubMed ID: 15948094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of brain natriuretic peptide and serum triiodothyronine in the diagnosis and prognosis of chronic heart failure.
    Du JB; Da CH; Zhao Y; Guo Y; Guo G; Ju TF; Xu YP
    Acta Cardiol; 2012 Jun; 67(3):291-6. PubMed ID: 22870736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
    Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
    J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
    Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
    Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
    Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
    Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients.
    Berezin AE; Kremzer AA; Samura TA; Martovitskaya YV; Malinovskiy YV; Oleshko SV; Berezina TA
    J Cardiol; 2015 May; 65(5):403-11. PubMed ID: 25123603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of serum myostatin for the severity and clinical outcome of heart failure.
    Chen P; Liu Z; Luo Y; Chen L; Li S; Pan Y; Lei X; Wu D; Xu D
    Eur J Intern Med; 2019 Jun; 64():33-40. PubMed ID: 31056368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2002 Mar; 39(6):957-62. PubMed ID: 11897436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.